A. Sugimoto

Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.

E. Eisenhauer, A. Oza, D. Provencher, 2010, Journal of the National Cancer Institute.

A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial

A. Oza, H. Hirte, Lisa I. Wang, 2008 .

Non-Hodgkin's lymphomas in Osaka, Japan.

K. Aozasa, M. Hanada, M. Sakurai, 1985, European journal of cancer & clinical oncology.

A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia.

A. Oza, H. Hirte, S. Lheureux, 2015, Gynecologic oncology.

Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.

E. Eisenhauer, A. Oza, D. Provencher, 2010, Journal of the National Cancer Institute.